IHydrochlorothiazide

Inkcazelo emfutshane:

Igama le-API Isalathiso Inkcazo I-USDMF EU DMF CEP
IHydrochlorothiazide I-Diuretics USP/EP/CEP 16750 CEP 2006-011


Iinkcukacha zeMveliso

Iithegi zeMveliso

IINKCUKACHA ZEMVELISO

Inkcazo

IHydrochlorothiazide (HCTZ), ichiza lomchamo elisebenzayo ngomlomo leklasi yethiazide, inqanda ukuguqula iTGF-β/Indlela yomqondiso weSmad. IHydrochlorothiazide ineziphumo ezithe ngqo zokuphumza imithambo ngokuvula umjelo we-calcium-activated potassium (KCA). IHydrochlorothiazide iphucula ukusebenza kwentliziyo, inciphisa i-fibrosis kwaye inefuthe le-antihypertensive.

Imvelaphi

IHydrochlorothiazide lichiza le-diuretic lodidi lwe-thiazide.

I-In vitro

IHydrochlorothiazide yeyodidi lwe-thiazide ye-diuretics. Inciphisa umthamo wegazi ngokusebenza kwizintso ukunciphisa i-sodium (Na) i-reabsorption kwi-distal convoluted tubule. Indawo enkulu yesenzo kwi-nephron ibonakala kwi-electroneutral ye-Na + -Cl co-transporter ngokukhuphisana nesiza se-chloride kwi-transporter. Ngokuphazamisa ukuhamba kwe-Na kwi-tubule e-distal convoluted, i-hydrochlorothiazide ibangela i-natriuresis kunye nokulahlekelwa kwamanzi okuhambelanayo. I-Thiazides yandisa ukubuyiswa kwakhona kwe-calcium kweli candelo ngendlela engahambelani nokuthuthwa kwe-sodium. Ukongezelela, ngezinye iindlela, i-Hydrochlorothiazide ikholelwa ukuba iyancipha ukuxhathisa kwe-vascular peripheral.

I-Hydrochlorothiazide (i-HCTZ; i-oral bygavage; i-12.5 mg / kg / d; iiveki ze-8) iphucule umsebenzi wenhliziyo, yanciphisa i-cardiac interstitial fibrosis kunye neqhekeza levolumu ye-collagen, ukunciphisa ukubonakaliswa kwe-AT1, TGF-β kunye ne-Smad2 kwiithishu zentliziyo kumadoda amadala e-Sprague Dawley rats. Ukongeza, i-hydrochlorothiazide inciphisa i-plasma angiotensin II kunye namanqanaba e-aldosterone. Ngapha koko, i-hydrochlorothiazide inqanda i-angiotensin II-induced TGF-βI-1 kunye ne-Smad2 inkcazo yeprotheni kwi-neonatal rat ventricular fibroblasts.

Ubume beMichiza

IHydrochlorothiazide

ISIQINISEKISO

2018 GMP-2
原料药GMP证书201811(captopril,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
I-FDA-EIR-Letter-201901

ULAWULO LOMgangatho

Ulawulo lomgangatho1

Isindululo18Iiprojekthi zoVavanyo loBulunga ezivunyiweyo4, kwaye6iiprojekthi ziphantsi kolwamkelo.

Ulawulo lomgangatho2

Inkqubo yolawulo lomgangatho wehlabathi ephucukileyo ibeke isiseko esiluqilima sokuthengisa.

Ulawulo lomgangatho3

Ukongamela umgangatho kuqhuba umjikelo wobomi bemveliso ukuqinisekisa umgangatho kunye nesiphumo sonyango.

Ulawulo lomgangatho4

Iqela leMicimbi yoLawulo lobuGcisa lixhasa iimfuno zomgangatho ngexesha lesicelo kunye nokubhaliswa.

ULAWULO LWEMVELISO

cpf5
cpf6

Korea Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Bottled UkuPakisha Line

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

Umatshini wokuQinisa iFette waseJamani

cpf12

Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UMQHUBA

Intsebenziswano yamazwe ngamazwe
Intsebenziswano yamazwe ngamazwe
Intsebenziswano yasekhaya
Intsebenziswano yasekhaya

  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha kwaye uwuthumele kuthi

    Iindidi zeemveliso